AJAY SHARMA: Open Payments
NPI 1336287002 · ZANESVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$91,685 in 316 payments from 20 companies in 2025. Trend: 2023 $59,673 · 2024 $67,061 · 2025 $91,685
Speaker / faculty: $45,775Honoraria: $23,325Consulting: $13,248Food & beverage: $6,066Travel & lodging: $3,272
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 42 | $28,603 |
| Axsome Therapeutics, Inc. | 33 | $25,658 |
| E.R. Squibb & Sons, L.L.C. | 71 | $19,252 |
| Alkermes, Inc. | 42 | $16,269 |
| ABBVIE INC. | 49 | $525 |
| Neurocrine BioSciences, Inc. | 19 | $310 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $222 |
| Supernus Pharmaceuticals, Inc. | 9 | $160 |
| Otsuka America Pharmaceutical, Inc. | 10 | $156 |
| Tris Pharma Inc | 6 | $113 |
Products named: CAPLYTA, Auvelity, COBENFY, LYBALVI, VRAYLAR, ARISTADA, INGREZZA, TRINTELLIX.
Industry payments across OH — which companies pay providers there.
